Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 298

1.

Emerging drugs for major depressive disorder.

Connolly KR, Thase ME.

Expert Opin Emerg Drugs. 2012 Mar;17(1):105-26. doi: 10.1517/14728214.2012.660146. Epub 2012 Feb 20. Review.

PMID:
22339643
2.

Emerging drugs for major depressive disorder.

Kennedy SH, Rizvi SJ.

Expert Opin Emerg Drugs. 2009 Sep;14(3):439-53. doi: 10.1517/14728210903107751. Review.

PMID:
19637989
3.

Vortioxetine: a New Treatment for Major Depressive Disorder.

Connolly KR, Thase ME.

Expert Opin Pharmacother. 2016;17(3):421-31. doi: 10.1517/14656566.2016.1133588. Review.

PMID:
26679430
4.
5.

Agomelatine treatment of major depressive disorder.

Dolder CR, Nelson M, Snider M.

Ann Pharmacother. 2008 Dec;42(12):1822-31. doi: 10.1345/aph.1L296. Epub 2008 Nov 25. Review.

PMID:
19033480
6.

Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs?

Fornaro M, Aguglia E, Dell'Osso L, Perugi G.

Expert Opin Pharmacother. 2011 Dec;12(18):2817-31. doi: 10.1517/14656566.2011.632366. Review.

PMID:
22098226
7.

Criticisms of drugs in early development for the treatment of depression: what can be improved?

Wang SM, Han C, Pae CU.

Expert Opin Investig Drugs. 2015 Apr;24(4):445-53. doi: 10.1517/13543784.2014.985784. Epub 2014 Dec 20.

PMID:
25529224
8.

Desvenlafaxine in the treatment of major depressive disorder.

Pae CU.

Expert Opin Pharmacother. 2011 Dec;12(18):2923-8. doi: 10.1517/14656566.2011.636033. Review.

PMID:
22098230
9.

A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine.

Deardorff WJ, Grossberg GT.

Expert Opin Pharmacother. 2014 Dec;15(17):2525-42. doi: 10.1517/14656566.2014.960842. Epub 2014 Sep 16. Review.

PMID:
25224953
10.

Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.

Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI.

J Clin Psychiatry. 2011 Dec;72(12):1660-8. doi: 10.4088/JCP.10r06531.

PMID:
22244025
11.

Second-generation antipsychotics in the treatment of major depressive disorder: current evidence.

Han C, Wang SM, Kato M, Lee SJ, Patkar AA, Masand PS, Pae CU.

Expert Rev Neurother. 2013 Jul;13(7):851-70. doi: 10.1586/14737175.2013.811901. Review.

PMID:
23898855
12.

[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].

Gourion D.

Encephale. 2008 Jan;34(1):73-81. doi: 10.1016/j.encep.2007.12.001. Epub 2008 Feb 5. Review. French.

PMID:
18514154
13.

A systematic review of augmentation strategies for patients with major depressive disorder.

Fleurence R, Williamson R, Jing Y, Kim E, Tran QV, Pikalov AS, Thase ME.

Psychopharmacol Bull. 2009;42(3):57-90. Review.

PMID:
19752841
15.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
16.

Intravenous ketamine for treatment-resistant major depressive disorder.

Covvey JR, Crawford AN, Lowe DK.

Ann Pharmacother. 2012 Jan;46(1):117-23. doi: 10.1345/aph.1Q371. Epub 2011 Dec 20. Review.

PMID:
22190250
17.

Vilazodone for the treatment of depression.

Lindsey WT.

Ann Pharmacother. 2011 Jul;45(7-8):946-53. doi: 10.1345/aph.1P772. Epub 2011 Jun 13. Review.

PMID:
21672888
18.

The future of psychopharmacology of depression.

Chang T, Fava M.

J Clin Psychiatry. 2010 Aug;71(8):971-5. doi: 10.4088/JCP.10m06223blu. Review.

PMID:
20797377
19.

Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.

Reddy S, Kane C, Pitrosky B, Musgnung J, Ninan PT, Guico-Pabia CJ.

Curr Med Res Opin. 2010 Jan;26(1):139-50. doi: 10.1185/03007990903408678. Review.

PMID:
19919295
20.

Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments.

Kennedy SH, Lam RW, Cohen NL, Ravindran AV; CANMAT Depression Work Group.

Can J Psychiatry. 2001 Jun;46 Suppl 1:38S-58S. Review.

PMID:
11441771

Supplemental Content

Support Center